Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system

[1]  W. Pardridge.  The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier , 2020, Frontiers in Physiology.

[2]  Y. Yoneda,et al.  Selective Upregulation by Theanine of Slc38a1 Expression in Neural Stem Cell for Brain Wellness , 2020, Molecules.

[3]  L. Xiong,et al.  Neuroprotective Autophagic Flux Induced by Hyperbaric Oxygen Preconditioning is Mediated by Cystatin C , 2018, Neuroscience Bulletin.

[4]  Hao Zhang,et al.  Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia , 2018, Autophagy.

[5]  Haichen Chu,et al.  Ulk1/FUNDC1 Prevents Nerve Cells from Hypoxia-Induced Apoptosis by Promoting Cell Autophagy , 2018, Neurochemical Research.

[6]  L. Zeng,et al.  Rapamycin prevents cerebral stroke by modulating apoptosis and autophagy in penumbra in rats , 2017, Annals of clinical and translational neurology.

[7]  Yongqing Guo.  Role of HIF-1a in regulating autophagic cell survival during cerebral ischemia reperfusion in rats , 2017, Oncotarget.

[8]  Lai Wang,et al.  Protective effect of autophagy in neural ischemia and hypoxia: Negative regulation of the Wnt/β-catenin pathway , 2017, International journal of molecular medicine.

[9]  Y. Liu,et al.  Increased SNAT1 is a marker of human osteosarcoma and potential therapeutic target , 2017, Oncotarget.

[10]  Z. Fei,et al.  Sirt3 confers protection against neuronal ischemia by inducing autophagy: Involvement of the AMPK‐mTOR pathway , 2017, Free radical biology & medicine.

[11]  Yuanjun Zhu,et al.  Increased autophagic degradation contributes to the neuroprotection of hydrogen sulfide against cerebral ischemia/reperfusion injury , 2017, Metabolic Brain Disease.

[12]  J. Jaworski,et al.  Molecular neurobiology of mTOR , 2017, Neuroscience.

[13]  K. Kawahara,et al.  Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer. , 2016, Biochemical and biophysical research communications.

[14]  K. Maiese.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. , 2016, British journal of clinical pharmacology.

[15]  K. Macleod,et al.  Autophagy in cancer metastasis , 2016, Oncogene.

[16]  T. Todo,et al.  Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance* , 2016, The Journal of Biological Chemistry.

[17]  K. Kawahara,et al.  mTORC1 is a critical mediator of oncogenic Semaphorin3A signaling. , 2016, Biochemical and biophysical research communications.

[18]  S. Bröer,et al.  Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells* , 2016, The Journal of Biological Chemistry.

[19]  H. Bian,et al.  Pharmacologic preconditioning with berberine attenuating ischemia-induced apoptosis and promoting autophagy in neuron. , 2016, American journal of translational research.

[20]  E. Ballestar,et al.  Autophagy maintains stemness by preventing senescence , 2016, Nature.

[21]  P. Marin,et al.  mTOR in Brain Physiology and Pathologies. , 2015, Physiological reviews.

[22]  K. Giacomini,et al.  SLC transporters as therapeutic targets: emerging opportunities , 2015, Nature Reviews Drug Discovery.

[23]  R. Fredriksson,et al.  Transport of L-glutamine, L-alanine, L-arginine and L-histidine by the neuron-specific Slc38a8 (SNAT8) in CNS. , 2015, Journal of molecular biology.

[24]  G. Cortopassi,et al.  Dysregulation of Glutamine Transporter SNAT1 in Rett Syndrome Microglia: A Mechanism for Mitochondrial Dysfunction and Neurotoxicity , 2015, The Journal of Neuroscience.

[25]  K. Guan,et al.  Differential regulation of mTORC1 by leucine and glutamine , 2015, Science.

[26]  J. Lipton,et al.  The Neurology of mTOR , 2014, Neuron.

[27]  Michelle Y. Cheng,et al.  Mammalian Target of Rapamycin Cell Signaling Pathway Contributes to the Protective Effects of Ischemic Postconditioning Against Stroke , 2014, Stroke.

[28]  M. Scalise,et al.  Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health , 2014, Front. Chem..

[29]  John R. Barrett,et al.  Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke , 2014, Experimental & Translational Stroke Medicine.

[30]  J. Simpkins,et al.  mTOR Signaling Inhibition Modulates Macrophage/Microglia-Mediated Neuroinflammation and Secondary Injury via Regulatory T Cells after Focal Ischemia , 2014, The Journal of Immunology.

[31]  Makoto Sato,et al.  Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease , 2014, Front. Behav. Neurosci..

[32]  R. Fredriksson,et al.  Histological Analysis of SLC38A6 (SNAT6) Expression in Mouse Brain Shows Selective Expression in Excitatory Neurons with High Expression in the Synapses , 2014, PloS one.

[33]  X. Ji,et al.  Ischemic post‐conditioning facilitates brain recovery after stroke by promoting Akt/mTOR activity in nude rats , 2013, Journal of neurochemistry.

[34]  T. Abe,et al.  An analysis of skeletal development in osteoblast‐specific and chondrocyte‐specific runt‐related transcription factor‐2 (Runx2) knockout mice , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  J. Pouysségur,et al.  Disrupting proton dynamics and energy metabolism for cancer therapy , 2013, Nature Reviews Cancer.

[36]  Michelle Y. Cheng,et al.  Akt Isoforms Differentially Protect against Stroke-Induced Neuronal Injury by Regulating mTOR Activities , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  R. Nixon,et al.  The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.

[38]  Ying Chen,et al.  Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression , 2013, BMC Cancer.

[39]  A. Buchan,et al.  Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy , 2013, Nature Medicine.

[40]  Sang Gyun Kim,et al.  Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex. , 2013, Molecular cell.

[41]  M. Malumbres,et al.  HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. , 2012, Molecular cell.

[42]  N. Nakamichi,et al.  Promotion of Both Proliferation and Neuronal Differentiation in Pluripotent P19 Cells with Stable Overexpression of the Glutamine Transporter slc38a1 , 2012, PloS one.

[43]  D. Kwiatkowski,et al.  Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. , 2012, Human molecular genetics.

[44]  E. Gottlieb,et al.  Glutaminolysis activates Rag-mTORC1 signaling. , 2012, Molecular cell.

[45]  Marta Martínez-Vicente,et al.  Fighting neurodegeneration with rapamycin: mechanistic insights , 2011, Nature Reviews Neuroscience.

[46]  R. Fredriksson,et al.  Identification of SLC38A7 (SNAT7) Protein as a Glutamine Transporter Expressed in Neurons* , 2011, The Journal of Biological Chemistry.

[47]  Y. Eishi,et al.  Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.

[48]  Y. Ishigaki,et al.  Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis , 2011, Laboratory Investigation.

[49]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[50]  C. James,et al.  Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma , 2010, Science Signaling.

[51]  Tibor Harkany,et al.  SAT1, A Glutamine Transporter, is Preferentially Expressed in GABAergic Neurons , 2009, Front. Neuroanat..

[52]  E. Hinoi,et al.  Interference by adrenaline with chondrogenic differentiation through suppression of gene transactivation mediated by Sox9 family members. , 2009, Bone.

[53]  Jeffrey P. MacKeigan,et al.  Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.

[54]  B. Manning,et al.  Common corruption of the mTOR signaling network in human tumors , 2008, Oncogene.

[55]  A. Hada,et al.  Activation of a system A amino acid transporter, ATA1/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. , 2007, International journal of oncology.

[56]  F. Jensen,et al.  A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival , 2007, The Journal of Neuroscience.

[57]  M. Hediger,et al.  Functional Properties and Cellular Distribution of the System A Glutamine Transporter SNAT1 Support Specialized Roles in Central Neurons* , 2003, Journal of Biological Chemistry.

[58]  Hongbing Zhang,et al.  A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.

[59]  J. Marth,et al.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. , 2001, Genes & development.

[60]  Y Ikawa,et al.  A novel ES cell line, TT2, with high germline-differentiating potency. , 1993, Analytical biochemistry.

[61]  G. Cortopassi,et al.  Neurobiology of Disease Dysregulation of Glutamine Transporter SNAT 1 in Rett Syndrome Microglia : A Mechanism for Mitochondrial Dysfunction and Neurotoxicity , 2015 .

[62]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.

[63]  E. ZLonga,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989 .

[64]  Mechanistic insights , 2022 .